GENESCO INC (GCO) earnings date, results and what the price requires
NYSE · SEC CIK 0000018498 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Aug 1, 2026 | Sep 3, 2026 | $529.9M | $3.5M | $0.32 | Filing |
| May 2, 2026 | May 29, 2026 | $487.0M | $-14.8M | $-1.42 | Filing |
| Jan 31, 2026 | Mar 6, 2026 | $799.9M | $47.3M | $4.56 | Filing |
| Nov 1, 2025 | Dec 4, 2025 | $616.2M | $5.4M | $0.50 | Filing |
| Aug 2, 2025 | Aug 28, 2025 | $546.0M | $-18.5M | $-1.79 | Filing |
| May 3, 2025 | Jun 4, 2025 | $474.0M | $-21.2M | $-2.02 | Filing |
| Feb 1, 2025 | Mar 7, 2025 | $745.9M | — | $3.16 | Filing |
| Jan 31, 2025 | Mar 7, 2025 | Announced; figures arrive with the 10-Q | $34.3M | — | Filing |
What would GENESCO INC have to report for its valuation to change?
At $37.42, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -4.2% a year, to $3.20. On that path the next quarter needs diluted EPS near $0.48, against $0.50 in the quarter ended Nov 1, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -4.2% | -4.2% |
| EPS needed in final year | $3.20 | $3.20 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. GCO goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.